Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia

计划入组 50 人 · 首次发布于 2007 年 5 月 4 日

Guanfacine to Treat Borderline Personality Disorder

首次发布于 2006 年 8 月 1 日

Prospective, Multicenter, RCT of the Tenex Ultrasound System

计划入组 148 人 · 首次发布于 2023 年 11 月 18 日

XELRYX-3

Nanozyme-e program 8 (Cenyx Biotech)

Zirconium-89 labelled antibody (Telix Pharmaceuticals)

Telix Pharmaceuticals

Australia

Tenax Therapeutics

United States

Telix Pharmaceuticals (US) Inc.

United States

Agentic AI Reshapes Healthcare Operations: From Scheduling to Drug Discovery, Autonomous Systems Demonstrate Measurable ROI

TelyRx Digital Pharmacy Platform Goes Public Through $40 Million SPAC Transaction

Cenyx Biotech Advances Nanozymes for Inflammatory Disease Treatment